Janis Niessen
Guest doctoral student at Department of Medical Cell Biology; Research group Markus Sjöblom
- E-mail:
- janis.niessen@uu.se
- Visiting address:
- BMC
Husargatan 3
751 23 Uppsala - Postal address:
- Box 571
751 23 UPPSALA
Guest doctoral student at Department of Medicinal Chemistry; Analytical Pharmaceutical Chemistry
- Visiting address:
- Uppsala biomedicinska centrum BMC, Husarg. 3
- Postal address:
- Box 574
751 23 UPPSALA
PhD student at Department of Pharmaceutical Biosciences; Research; Translational Drug Discovery and Development
- E-mail:
- janis.niessen@uu.se
- Visiting address:
- BMC, Husargatan 3
75124 Uppsala - Postal address:
- Box 591
75124 Uppsala
Publications
Recent publications
-
Part of Journal of Controlled Release, 2026
- DOI for Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats
- Download full text (pdf) of Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats
-
Part of Molecular Pharmaceutics, p. 3445-3457, 2026
- DOI for The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant)
- Download full text (pdf) of The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant)
-
Part of Clinical Therapeutics, p. 544-545, 2026
-
Part of European journal of pharmaceutics and biopharmaceutics, 2025
- DOI for A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats
- Download full text (pdf) of A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats
-
Part of Journal of Pharmaceutical and Biomedical Analysis, 2024
- DOI for Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471)
- Download full text (pdf) of Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471)
All publications
Articles in journal
-
Part of Journal of Controlled Release, 2026
- DOI for Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats
- Download full text (pdf) of Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats
-
Part of Molecular Pharmaceutics, p. 3445-3457, 2026
- DOI for The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant)
- Download full text (pdf) of The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant)
-
Part of Clinical Therapeutics, p. 544-545, 2026
-
Part of European journal of pharmaceutics and biopharmaceutics, 2025
- DOI for A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats
- Download full text (pdf) of A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats
-
Part of Journal of Pharmaceutical and Biomedical Analysis, 2024
- DOI for Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471)
- Download full text (pdf) of Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471)